Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026. On December 30, ...
Zacks Investment Research on MSN
Here is what to know beyond why Johnson & Johnson (JNJ) is a trending stock
Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
If you are wondering whether Johnson & Johnson shares still offer solid value after a strong run, this article will walk ...
As an aside, see 3 Risks That Can Make UnitedHealth Stock Unattractive. Additionally, see: MSFT Stock A Winner In 2026? JNJ ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
The average one-year price target for Johnson & Johnson (NYSE:JNJ) has been revised to $204.02 / share. This is an increase of 10.96% from the prior estimate of $183.86 dated September 27, 2025. The ...
Johnson & Johnson (NYSE:JNJ) is included among the 15 Dividend Stocks that Outperform the S&P 500. Barclays lifted its price target on Johnson & Johnson (NYSE:JNJ) to $197 from $176 on December 2 ...
Johnson & Johnson (NYSE:JNJ) stock is down 1.2% to trade at $188.54 at last glance, brushing off an earnings and revenue beat for the third quarter. The pharma company also announced it will spin off ...
The average one-year price target for Johnson & Johnson (XTRA:JNJ) has been revised to 175,39 € / share. This is an increase of 11.93% from the prior estimate of 156,70 € dated September 29, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback